» Authors » M A Vermeer

M A Vermeer

Explore the profile of M A Vermeer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 525
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kroon M, Koolwijk P, Vermeer M, van der Vecht B, van Hinsbergh V
Thromb Haemost . 2001 Mar; 85(2):296-302. PMID: 11246551
Among other proteolytic enzymes, the urokinase-type plasminogen activator (u-PA)/plasmin cascade contributes to cell migration and the formation of capillary-like structures in a fibrinous exudate. The u-PA receptor (u-PAR) focuses proteolytical...
2.
van Nieuw Amerongen G, Vermeer M, van Hinsbergh V
Arterioscler Thromb Vasc Biol . 2000 Dec; 20(12):E127-33. PMID: 11116077
In the present study, the roles of the small GTPase RhoA and its target Rho kinase in endothelial permeability were investigated in vitro. We have shown previously that, in addition...
3.
van Nieuw Amerongen G, van Delft S, Vermeer M, Collard J, van Hinsbergh V
Circ Res . 2000 Aug; 87(4):335-40. PMID: 10948069
Endothelial cells (ECs) actively regulate the extravasation of blood constituents. On stimulation by vasoactive agents and thrombin, ECs change their cytoskeletal architecture and small gaps are formed between neighboring cells....
4.
te Loo D, Monnens L, van Der Velden T, Vermeer M, Preyers F, Demacker P, et al.
Blood . 2000 May; 95(11):3396-402. PMID: 10828021
The hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in children. The role of a verocytotoxin (VT)-producing Escherichia coli has been strongly implicated in the...
5.
van Nieuw Amerongen G, Vermeer M, Lankelma J, Emeis J, van Hinsbergh V
Circulation . 2000 Jan; 102(23):2803-9. PMID: 11104736
Background: Recent clinical trials have established that inhibitors of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) reduce the risk of acute coronary events. These effects of statins cannot be fully...
6.
van Nieuw Amerongen G, Draijer R, Vermeer M, van Hinsbergh V
Circ Res . 1998 Dec; 83(11):1115-23. PMID: 9831706
In the present study, we differentiated between short- and long-term effects of vasoactive compounds on human endothelial permeability in an in vitro model. Histamine induced a rapid and transient (<3...
7.
Schalkwijk C, Vermeer M, Stehouwer C, te Koppele J, Princen H, van Hinsbergh V
Biochim Biophys Acta . 1998 Oct; 1394(2-3):187-98. PMID: 9795211
In patients with diabetes, non-enzymatic glycation of low-density lipoprotein (LDL) has been suggested to be involved in the development of atherosclerosis. alpha-Dicarbonyl compounds were identified as intermediates in the non-enzymatic...
8.
Koolwijk P, Van Erck M, de Vree W, Vermeer M, Weich H, Hanemaaijer R, et al.
J Cell Biol . 1996 Mar; 132(6):1177-88. PMID: 8601593
In angiogenesis associated with tissue repair and disease, fibrin and inflammatory mediators are often involved. We have used three-dimensional fibrin matrices to investigate the humoral requirements of human microvascular endothelial...
9.
de Vries A, Vermeer M, Bredman J, Bar P, Cohen L
Exp Eye Res . 1993 Apr; 56(4):393-9. PMID: 8500554
The influence of the 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors pravastatin and simvastatin on lens cholesterol metabolism was investigated in the rat. Short-term organ culture experiments with explanted lenses from...
10.
de Vries A, Vermeer M, Bloemendal H, Cohen L
Invest Ophthalmol Vis Sci . 1993 Feb; 34(2):377-84. PMID: 8440592
Purpose: In the current study, the hypocholesterolemic drugs pravastatin and simvastatin were compared for their influence on cholesterol biosynthesis in the human lens. Methods: For measurements of cholesterol and fatty...